HIV prevention policy: latest news

HIV prevention policy resources

HIV prevention policy features

HIV prevention policy news from aidsmap

More news

HIV prevention policy news selected from other sources

  • Bouquets and brickbats for India's fight against TB, HIV and Malaria

    India will become the first country from the global south to host a Preparatory Meeting of the Global Fund to Fight AIDS, TB and Malaria, slated to be held in the national capital on February 7 and 8.

    12 hours ago | THE WEEK
  • Philippines: Beyond the new HIV and AIDS law

    The new HIV and AIDS law is a welcome piece of legislation but much work needs to be done if we are to address the HIV crisis. Here are some challenges - and steps to deal with them.

    17 January 2019 | Inquirer
  • NHS hope to double capacity of PrEP trial after huge demand for HIV prevention drug

    Deborah Gold, Chief Executive of NAT (National AIDS Trust), said: “Having been pushing for increased access to PrEP for so long, we are pleased that NHS England has listened to us and agreed to fund more spaces for PrEP patients on the Impact trial. It has been completely unacceptable to see people in need of PrEP being turned away from clinics."

    11 January 2019 | National AIDS Trust
  • Micro-level mapping in Zimbabwe identifies key HIV hotspots

    A detailed geographic analysis of Zimbabwe's HIV epidemic indicates the greatest concentrations of people living with HIV who lack treatment are in the country’s main cities and urban settlements.

    11 January 2019 | Avert
  • NHS England announces support for doubling PrEP trial

    NHS England announced on Friday (11 January) its support for a request from researchers leading the PrEP IMPACT Trial. The request asks for the trial to double its places. This would give 26,000 people access to the life-saving pill, compared to the former 13,000 people.

    11 January 2019 | Gay Star News
  • PrEP: Postcode lottery of anti-HIV drug trial

    A game-changer in the fight against HIV, pre-exposure prophylaxis (PrEP) is a highly effective drug that reduces the risk of acquiring the condition. But as the NHS trials PrEP across England, many at high risk have struggled to get hold of the drug.

    11 January 2019 | BBC News
  • Alarming rise in HIV infections in the Philippines: what it must do

    While many countries, including in Southeast Asia, have seen a fall in new HIV infections, the Philippines has seen a sharp rise. Bureaucracy, a conservative society and the Catholic Church are the main stumbling blocks to effective action

    03 January 2019 | South China Morning Post
  • MPs warn of ‘cliff-edge’ in access to HIV prevention pill PrEP in open letter to Public Health Minister calling for ‘urgent action’

    MPs and peers have written an open letter calling on the Public Health Minister to urgently expand access to PrEP.

    20 December 2018 | Terrence Higgins Trust
  • Adolescents key to achieving HIV control targets in Uganda

    Despite substantial reductions in prevalence and incidence of HIV in Uganda, prevention shortfalls might hamper goals to achieve epidemic control by 2030. Esther Nakkazi reports.

    17 December 2018 | The Lancet HIV (requires free registration)
  • Councils call for major extension of national HIV prevention trial

    The Association of Directors of Public Health (ADPH) and Local Government Association (LGA) are calling for a major extension of access to PrEP to help end the epidemic of HIV in the UK. ADPH and LGA fully support PrEP as part of an effective HIV prevention strategy, with the potential to save lives. Our only concern is the unfunded cost to councils as a result of rolling PrEP out, whether as part of expanding the number of people on the PrEP Trial or in a future national HIV PrEP programme. We are calling for the forthcoming NHS long-term plan to commit to fully fund expanded access to the HIV PrEP Trial ensuring that both unresolved implementation questions are addressed and that local authority sexual health services are adequately resourced to support this extension.

    14 December 2018 | The Association of Directors of Public Health
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.